Stefania Spila-Alegiani

10PUBLICATIONS
33CO-AUTHORS
Infant and child healthTransplantation immunologyNanotoxicology, health and safetyMedical infection agents (incl. prions)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 09, 2026
Safety of nirsevimab in children aged 0-24 months: Analysis based on EudraVigilance data (2023-2025).

|Nov 12, 2024
Maintenance immunosuppressive therapy in liver transplantation: results from CESIT study, an Italian retrospective cohort study.

Arianna Bellini, Marco Finocchietti, Alessandro Cesare Rosa

|Oct 16, 2024
The Importance of Real-World Data in Evaluating the Safety of Biosimilars: A Descriptive Study of Clinical Practice in an Oncohematological Italian Population.

Silvana A M Urru, Flavia Mayer, Stefania Spila Alegiani

|Jul 27, 2024
Acute Appendicitis After COVID-19 Vaccines in Italy: A Self-Controlled Case Series Study.

Cristina Morciano, Marco Massari, Maria Cutillo

|Jan 17, 2024
Immunosuppression with Generics in Liver and Kidney Transplantation: A Real-World Evidence Study.

Marco Finocchietti, Maria Lucia Marino, Alessandro C Rosa

|Aug 07, 2023
Postmarketing observational study on the safety of 2021/2022 and 2022/2023 influenza vaccination campaigns in Italy: TheShinISS-Vax|Flu study protocol.

Stefania Spila Alegiani, Cristina Morciano, Francesca Menniti-Ippolito

Pageof 2

Frequent Collaborators

7 joint publications

Marco Massari

4 joint publications

Cristina Morciano

4 joint publications

Valeria Belleudi

3 joint publications

Gianluca Trifirò